BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1765775)

  • 1. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.
    Erdman DD; Usher MJ; Tsou C; Caul EO; Gary GW; Kajigaya S; Young NS; Anderson LJ
    J Med Virol; 1991 Oct; 35(2):110-5. PubMed ID: 1765775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of human parvovirus B19 DNA using PCR and serological test using ELISA for diagnosis of infection].
    Saito Y; Ikegaya K; Yano S; Yamauchi T; Hikiji K
    Rinsho Byori; 1993 Feb; 41(2):203-8. PubMed ID: 8361022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis of parvovirus B19 infection.
    Sevall JS; Ritenhous J; Peter JB
    J Clin Lab Anal; 1992; 6(4):171-5. PubMed ID: 1403335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique.
    Török TJ; Wang QY; Gary GW; Yang CF; Finch TM; Anderson LJ
    Clin Infect Dis; 1992 Jan; 14(1):149-55. PubMed ID: 1571420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
    Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
    Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between human parvovirus B19 infection and arthritis.
    Cassinotti P; Bas S; Siegl G; Vischer TL
    Ann Rheum Dis; 1995 Jun; 54(6):498-500. PubMed ID: 7632094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerase chain reaction with double primer pairs for detection of human parvovirus B19 induced aplastic crises in family outbreaks.
    Fridell E; Békássy AN; Larsson B; Eriksson BM
    Scand J Infect Dis; 1992; 24(3):275-82. PubMed ID: 1509232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 infection--persistence and genetic variation.
    Kerr JR; Curran MD; Moore JE; Murphy PG
    Scand J Infect Dis; 1995; 27(6):551-7. PubMed ID: 8685632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva.
    Cubel RC; Oliveira SA; Brown DW; Cohen BJ; Nascimento JP
    J Clin Microbiol; 1996 Jan; 34(1):205-7. PubMed ID: 8748306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of specific immunoglobulin M and immunoglobulin G for parvovirus B19 diagnosis in patients with acute lymphoblastic leukemia receiving chemotherapy: prospective study.
    el-Sayed Zaki M
    Arch Pathol Lab Med; 2007 Nov; 131(11):1697-9. PubMed ID: 17979489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY; Lee KL; Hung CC
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fluid: Non-invasive alternative for parvovirus B19 diagnosis?
    Bodewes R; Kerkhof J; Cremer J; Gijselaar DB; Voordouw BCG; Veldhuijzen IK; Schipper M; van Binnendijk R
    J Clin Virol; 2019 Aug; 117():5-10. PubMed ID: 31128380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals.
    Heegaard ED; Petersen BL; Heilmann CJ; Hornsleth A
    J Clin Microbiol; 2002 Mar; 40(3):933-6. PubMed ID: 11880419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of human parvovirus B19 DNA detection in blood donors.
    Yoto Y; Kudoh T; Haseyama K; Suzuki N; Oda T; Katoh T; Takahashi T; Sekiguchi S; Chiba S
    Br J Haematol; 1995 Dec; 91(4):1017-8. PubMed ID: 8547113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
    Dobec M; Juchler A; Flaviano A; Kaeppeli F
    Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological diagnosis for human parvovirus B19 infection by an enzyme immunoassay kit with recombinant antigens synthesized in a baculovirus expression system].
    Yoto Y; Kudoh T; Haseyama K; Chiba S; Matsunaga Y; Yamazaki S
    Kansenshogaku Zasshi; 1995 Oct; 69(10):1135-40. PubMed ID: 7499916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Established fibromyalgia syndrome and parvovirus B19 infection.
    Berg AM; Naides SJ; Simms RW
    J Rheumatol; 1993 Nov; 20(11):1941-3. PubMed ID: 8308782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period.
    Rao SP; Miller ST; Cohen BJ
    Am J Dis Child; 1992 Nov; 146(11):1328-30. PubMed ID: 1415073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of clinical, molecular, and serological features in the diagnosis of parvovirus B19 infection in children.
    Onel M; Varkal MA; Yildiz I; Guven O; Unuvar E; Uysal HK; Agacfidan A
    Diagn Microbiol Infect Dis; 2024 Aug; 109(4):116300. PubMed ID: 38759541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.